242 related articles for article (PubMed ID: 29519936)
1. Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.
Katigbak A; Robert F; Paquet M; Pelletier J
G3 (Bethesda); 2018 May; 8(5):1627-1635. PubMed ID: 29519936
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
3. Designing Genetically Engineered Mouse Models (GEMMs) Using CRISPR Mediated Genome Editing.
Desjardins J; Cowan M; Yamanaka Y
Methods Mol Biol; 2022; 2429():515-531. PubMed ID: 35507186
[TBL] [Abstract][Full Text] [Related]
4. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
5. Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling.
Jo N; Sogabe Y; Yamada Y; Ukai T; Kagawa H; Mitsunaga K; Woltjen K; Yamada Y
Cancer Sci; 2019 Mar; 110(3):926-938. PubMed ID: 30588718
[TBL] [Abstract][Full Text] [Related]
6. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
Pritchard CEJ; Kroese LJ; Huijbers IJ
Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
[TBL] [Abstract][Full Text] [Related]
7. Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery.
Lundin A; Porritt MJ; Jaiswal H; Seeliger F; Johansson C; Bidar AW; Badertscher L; Wimberger S; Davies EJ; Hardaker E; Martins CP; James E; Admyre T; Taheri-Ghahfarokhi A; Bradley J; Schantz A; Alaeimahabadi B; Clausen M; Xu X; Mayr LM; Nitsch R; Bohlooly-Y M; Barry ST; Maresca M
Nat Commun; 2020 Sep; 11(1):4903. PubMed ID: 32994412
[TBL] [Abstract][Full Text] [Related]
8. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci.
Chylinski K; Hubmann M; Hanna RE; Yanchus C; Michlits G; Uijttewaal ECH; Doench J; Schramek D; Elling U
Nat Commun; 2019 Nov; 10(1):5454. PubMed ID: 31784531
[TBL] [Abstract][Full Text] [Related]
10. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
[TBL] [Abstract][Full Text] [Related]
11. Generating Genetically Modified Mice: A Decision Guide.
Huijbers IJ
Methods Mol Biol; 2017; 1642():1-19. PubMed ID: 28815490
[TBL] [Abstract][Full Text] [Related]
12. Generation of Genetically Modified Mice Using CRISPR/Cas9.
Muñoz-Santos D; Montoliu L; Fernández A
Methods Mol Biol; 2020; 2110():129-138. PubMed ID: 32002906
[TBL] [Abstract][Full Text] [Related]
13. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
14. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
Thamodaran V; Rani S; Velayudhan SR
Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
[TBL] [Abstract][Full Text] [Related]
16. Generation of a Knockout Mouse Embryonic Stem Cell Line Using a Paired CRISPR/Cas9 Genome Engineering Tool.
Wettstein R; Bodak M; Ciaudo C
Methods Mol Biol; 2016; 1341():321-43. PubMed ID: 25762293
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-mediated genome editing and guide RNA design.
Wiles MV; Qin W; Cheng AW; Wang H
Mamm Genome; 2015 Oct; 26(9-10):501-10. PubMed ID: 25991564
[TBL] [Abstract][Full Text] [Related]
18. Use of two gRNAs for CRISPR/Cas9 improves bi-allelic homologous recombination efficiency in mouse embryonic stem cells.
Acosta S; Fiore L; Carota IA; Oliver G
Genesis; 2018 May; 56(5):e23212. PubMed ID: 29676032
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing: CRISPR-Cas9.
Hoof JB; Nødvig CS; Mortensen UH
Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
[TBL] [Abstract][Full Text] [Related]
20. Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells.
Kissling L; Monfort A; Swarts DC; Wutz A; Jinek M
Methods Enzymol; 2019; 616():241-263. PubMed ID: 30691645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
